Skip to main content
. 2015 May 11;10(5):e0126128. doi: 10.1371/journal.pone.0126128

Fig 2. Receiver operating characteristic curves were used to determine the cutoff score for Ano1 overexpression in breast cancer.

Fig 2

The sensitivity and specificity for each outcome were plotted and the areas under curve (AUCs) and p value were indicated. A. Histological grade; B. Clinical stages; C. ER status; D. PR status; E. HER2 status; F. TNBC status; G. OS; H. Tamoxifen treatment.